Janus Global Life Sciences Fund

Scorecard
4 / 5 Stars
Lipper
5 5 5 2 4
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
5 / 5 Stars
TheStreet.com
A+ (Buy)

Fund Holdings

Asset Allocation

% Long % Net
Cash 2.16 2.16
Stocks 72.45 72.45
Bonds 0.0 0.0
Other 0.54 0.54
Foreign Bonds 0.0 0.0
Foreign Stocks 24.04 24.04
Convertible 0.81 0.81
Preferred 0.0 0.0

Updated 12.31.2013

Top 10 Holdings

Performance as of 03.31.2014

Portfolio as of 12.31.2013

Ticker YTD Return % % Net Assets
Gilead Sciences Inc GILD -1.94 4.71
Express Scripts ESRX 8.31 3.13
Aetna Inc AET 9.75 3.09
Celgene Corporation CELG -13.24 2.9
Roche Holding AG RHHVF 9.18 2.53
Biogen Idec Inc BIIB 10.81 2.48
Valeant Pharmaceuticals International Inc VRX 13.5 2.28
NPS Pharmaceuticals Inc NPSP -0.59 2.18
Johnson & Johnson JNJ 7.65 2.17
Medivation, Inc. MDVN 3.1 1.96